Ana Gil-Brusola
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ana Gil-Brusola has a total of 227 co-authors. Here are the top co-authors by number of shared publications:
- Iñaki Comas
Institute of Biomedicine of Valencia IBV-CSIC
7 shared publications Anaid Calle-Andrino
2 shared publications- Begoña Fuster Escrivá
Departamento de Microbiología, Consorcio Hospital General Universitario de Valencia, 46014 Valencia, Spain
2 shared publications Concepción Gimeno
2 shared publications- Concepción Gimeno-Cardona
Consorcio Hospital General Universitario de Valencia, Spain
2 shared publications David Navarro
2 shared publications
Latest Publications
- Open Access
- 6 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Complete genomes reveal a refined map of Mycobacterium tuberculosis genetic diversity across evolutionary scales
Elucidating the evolution and epidemiology of Mycobacterium tuberculosis requires comprehensive characterization of its genomic diversity; however, short-read sequencing fails to resolve part of this variation. Here, we assembled 216 complete genomes from clinical isolates in the Valencia Region, Spain, using long-read sequencing. This dataset, mostly encompassing Lineage 4, provides a refined map of M. tuberculosis genetic diversity across evolutionary scales. Complete genomes uncover a median of 312 (−1 to 792) additional SNPs per pairwise comparison, revealing an estimated evolutionary rate 1.44-fold higher than that inferred from short-read mapping. This diversity is concentrated in discrete hotspots, particularly within the pe/ppe gene family, where gene conversion is a major driver of nucleotide diversity. While most PE/PPE epitopes remain highly conserved, suggesting strong purifying selection, some involved in vaccine candidates are affected by gene conversion, with unknown consequences. At the epidemiological scale, additional resolution is gained from SNPs previously masked and newly resolved indels and structural variation, refining genetic transmission networks. Finally, at the within-host level, the use of patient-specific reference genomes allows us to capture genuine diversity during infection, showing that previous approaches led to false positive calls. Together, these findings delineate the landscape of M. tuberculosis genomic diversity and provide a framework for more accurate inference of pathogen evolution, host–pathogen interactions, and transmission dynamics.
- 6 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessComplete genomes reveal a refined map of Mycobacterium tuberculosis genetic diversity across evolutionary scales
Elucidating the evolution and epidemiology of Mycobacterium tuberculosis requires comprehensive characterization of its genomic diversity; however, short-read sequencing fails to resolve part of this variation. Here, we assembled 216 complete genomes from clinical isolates in the Valencia Region, Spain, using long-read sequencing. This dataset, mostly encompassing Lineage 4, provides a refined map of M. tuberculosis genetic diversity across evolutionary scales. Complete genomes uncover a median of 312 (−1 to 792) additional SNPs per pairwise comparison, revealing an estimated evolutionary rate 1.44-fold higher than that inferred from short-read mapping. This diversity is concentrated in discrete hotspots, particularly within the pe/ppe gene family, where gene conversion is a major driver of nucleotide diversity. While most PE/PPE epitopes remain highly conserved, suggesting strong purifying selection, some involved in vaccine candidates are affected by gene conversion, with unknown consequences. At the epidemiological scale, additional resolution is gained from SNPs previously masked and newly resolved indels and structural variation, refining genetic transmission networks. Finally, at the within-host level, the use of patient-specific reference genomes allows us to capture genuine diversity during infection, showing that previous approaches led to false positive calls. Together, these findings delineate the landscape of M. tuberculosis genomic diversity and provide a framework for more accurate inference of pathogen evolution, host–pathogen interactions, and transmission dynamics.
- Open Access
- 27 February 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (5) , 1612
Predominant Pneumococcal Serotypes in Isolates Causing Invasive Disease in a Spanish Region: An Examination of Their Association with Clinical Factors, Antimicrobial Resistance, and Vaccination Coverage
Background: Streptococcus pneumoniae (S. pneumoniae) remains a leading cause of morbidity and mortality, particularly among vulnerable populations. This study investigates the epidemiology of pneumococcal serotypes associated with invasive pneumococcal disease (IPD) in the Comunidad Valenciana (CV) region, Spain, analysing 1587 isolates collected from 2014 to 2023. Methods: Serotyping and antimicrobial susceptibility testing were performed, and whole-genome sequencing was conducted on 104 isolates to explore their clonal relationships. Results: The most prevalent serotype was serotype 8 (17.5%), followed by serotype 3 (14.7%), with a notable increase in serotype 8 cases from 2019 onwards and a decline in serotype 19A being observed. Age distribution played a role, as serotype 8 was more frequent in individuals over ten years old. The overall recovery rate was 72%, while serotypes 3 and 15A exhibited the highest mortality rates. The vaccination coverage was highest among children under five, underscoring the need for continued surveillance to evaluate vaccine effectiveness. The antimicrobial resistance was most pronounced for erythromycin (20%) and clindamycin (16%), with serotypes 19A and 6C displaying the highest resistance levels. Whole-genome sequencing identified sequence type (ST) 53 and ST180 as the predominant STs for serotypes 8 and 3, respectively, mirroring global trends. Conclusions: These findings emphasize the necessity of continuous monitoring to inform vaccination policies and antimicrobial strategies, to ensure effective disease control and improved patient outcomes.
- 27 February 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (5) , 1612
Open AccessPredominant Pneumococcal Serotypes in Isolates Causing Invasive Disease in a Spanish Region: An Examination of Their Association with Clinical Factors, Antimicrobial Resistance, and Vaccination Coverage
Background: Streptococcus pneumoniae (S. pneumoniae) remains a leading cause of morbidity and mortality, particularly among vulnerable populations. This study investigates the epidemiology of pneumococcal serotypes associated with invasive pneumococcal disease (IPD) in the Comunidad Valenciana (CV) region, Spain, analysing 1587 isolates collected from 2014 to 2023. Methods: Serotyping and antimicrobial susceptibility testing were performed, and whole-genome sequencing was conducted on 104 isolates to explore their clonal relationships. Results: The most prevalent serotype was serotype 8 (17.5%), followed by serotype 3 (14.7%), with a notable increase in serotype 8 cases from 2019 onwards and a decline in serotype 19A being observed. Age distribution played a role, as serotype 8 was more frequent in individuals over ten years old. The overall recovery rate was 72%, while serotypes 3 and 15A exhibited the highest mortality rates. The vaccination coverage was highest among children under five, underscoring the need for continued surveillance to evaluate vaccine effectiveness. The antimicrobial resistance was most pronounced for erythromycin (20%) and clindamycin (16%), with serotypes 19A and 6C displaying the highest resistance levels. Whole-genome sequencing identified sequence type (ST) 53 and ST180 as the predominant STs for serotypes 8 and 3, respectively, mirroring global trends. Conclusions: These findings emphasize the necessity of continuous monitoring to inform vaccination policies and antimicrobial strategies, to ensure effective disease control and improved patient outcomes.
- Open Access
- 16 January 2025
- Published by MDPI AG in Preprints.org
Predominant Pneumococcal Serotypes in Isolates Producing Invasive Disease in a Spanish Region: Study of Their Relationship with Clinical Factors, Antimicrobial Resistance and Vaccination Coverage
Pneumococcus is a significant pathogen due to its high morbidity and mortality rates, especially among vulnerable populations. This study investigates the epidemiology of Streptococcus pneumoniae serotypes causing invasive pneumococcal disease in the Region of Comunidad Valenciana, analyzing data from 1587 isolates collected between 2014 and 2023. Serotyping and antimicrobial sensitivity were assessed, and whole genome sequencing was conducted on 104 isolates to examine clonal relationships. The study found that serotype 8 was the most common (17.5%), followed by serotype 3 (14.7%). There were significant variations in serotype distribution over the years, with serotype 8 increasing notably from 2019 onwards, while serotype 19A has decreased. Age was a significant factor, with serotype 8 being more prevalent in individuals older than 10 years. The overall patient recovery rate was 72%, with the higher mortality observed in serotypes 3 and 15A. Vaccination rates were higher among children under five, and the study highlighted the necessity for continuous monitoring of vaccine efficacy. Antimicrobial resistance was most significant for erythromycin (20%) and clindamycin (16%), with serotypes 19A and 6C showing the highest resistance rates. Whole genome sequencing revealed that ST53 and ST180 were the predominant sequence types for serotypes 8 and 3, respectively, reflecting global trend. The study underscores the importance of ongoing surveillance to adapt vaccination strategies and antimicrobial treatments, given the dynamic nature of pneumococcal epidemiology and resistance patterns. The findings also emphasize the need for targeted interventions to manage high-risk serotypes and improve patient outcomes.
- 16 January 2025
- Published by MDPI AG in Preprints.org
Open AccessPredominant Pneumococcal Serotypes in Isolates Producing Invasive Disease in a Spanish Region: Study of Their Relationship with Clinical Factors, Antimicrobial Resistance and Vaccination Coverage
Pneumococcus is a significant pathogen due to its high morbidity and mortality rates, especially among vulnerable populations. This study investigates the epidemiology of Streptococcus pneumoniae serotypes causing invasive pneumococcal disease in the Region of Comunidad Valenciana, analyzing data from 1587 isolates collected between 2014 and 2023. Serotyping and antimicrobial sensitivity were assessed, and whole genome sequencing was conducted on 104 isolates to examine clonal relationships. The study found that serotype 8 was the most common (17.5%), followed by serotype 3 (14.7%). There were significant variations in serotype distribution over the years, with serotype 8 increasing notably from 2019 onwards, while serotype 19A has decreased. Age was a significant factor, with serotype 8 being more prevalent in individuals older than 10 years. The overall patient recovery rate was 72%, with the higher mortality observed in serotypes 3 and 15A. Vaccination rates were higher among children under five, and the study highlighted the necessity for continuous monitoring of vaccine efficacy. Antimicrobial resistance was most significant for erythromycin (20%) and clindamycin (16%), with serotypes 19A and 6C showing the highest resistance rates. Whole genome sequencing revealed that ST53 and ST180 were the predominant sequence types for serotypes 8 and 3, respectively, reflecting global trend. The study underscores the importance of ongoing surveillance to adapt vaccination strategies and antimicrobial treatments, given the dynamic nature of pneumococcal epidemiology and resistance patterns. The findings also emphasize the need for targeted interventions to manage high-risk serotypes and improve patient outcomes.
Accuracy of Xpert Ultra for the diagnosis of paediatric tuberculosis in a low TB burden country: a prospective multicentre study
Introduction Childhood pulmonary tuberculosis (TB) remains a diagnostic challenge. This study aimed to evaluate the performance of Xpert Ultra for the diagnosis of pulmonary TB in children in a low TB prevalence setting. Methods Prospective, multicentre, diagnostic accuracy study. Children with clinical or radiological suspicion of pulmonary TB were recruited at 11 paediatric units in Spain. Up to three gastric or sputum specimens were taken on 3 consecutive days, and analysed by Xpert MTB/RIF, Xpert Ultra and culture in parallel. Results 86 children were included (median age 4.9 years, IQR 2.0–10.0; 51.2% male). The final diagnosis was pulmonary TB in 75 patients (87.2%); 33 (44.0%) were microbiologically confirmed. A total of 219 specimens, comprising gastric aspirates (n=194; 88.6%) and sputum specimens (n=25; 11.4%), were analysed. Using culture as reference standard and comparing individual specimens, the sensitivity was 37.8% (14/37) for Xpert MTB/RIF and 81.1% (30/37) for Xpert Ultra (pConclusions In children with pulmonary TB in a low burden setting, Xpert Ultra has significantly higher sensitivity than the previous generation of Xpert assay and only marginally lower specificity. Therefore, in children undergoing evaluation for suspected pulmonary TB, Xpert Ultra should be used in preference to Xpert MTB/RIF whenever possible.
Accuracy of Xpert Ultra for the diagnosis of paediatric tuberculosis in a low TB burden country: a prospective multicentre study
Introduction Childhood pulmonary tuberculosis (TB) remains a diagnostic challenge. This study aimed to evaluate the performance of Xpert Ultra for the diagnosis of pulmonary TB in children in a low TB prevalence setting. Methods Prospective, multicentre, diagnostic accuracy study. Children with clinical or radiological suspicion of pulmonary TB were recruited at 11 paediatric units in Spain. Up to three gastric or sputum specimens were taken on 3 consecutive days, and analysed by Xpert MTB/RIF, Xpert Ultra and culture in parallel. Results 86 children were included (median age 4.9 years, IQR 2.0–10.0; 51.2% male). The final diagnosis was pulmonary TB in 75 patients (87.2%); 33 (44.0%) were microbiologically confirmed. A total of 219 specimens, comprising gastric aspirates (n=194; 88.6%) and sputum specimens (n=25; 11.4%), were analysed. Using culture as reference standard and comparing individual specimens, the sensitivity was 37.8% (14/37) for Xpert MTB/RIF and 81.1% (30/37) for Xpert Ultra (pConclusions In children with pulmonary TB in a low burden setting, Xpert Ultra has significantly higher sensitivity than the previous generation of Xpert assay and only marginally lower specificity. Therefore, in children undergoing evaluation for suspected pulmonary TB, Xpert Ultra should be used in preference to Xpert MTB/RIF whenever possible.
- Open Access
- 1 August 2020
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 56 (8) , 493-498
Tuberculosis Following Lung Transplantation. A 27-Year Spanish Multicenter Experience. Incidence, Presentation, Prevention and Treatment with Rifampicin
- 1 August 2020
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 56 (8) , 493-498
Open AccessTuberculosis Following Lung Transplantation. A 27-Year Spanish Multicenter Experience. Incidence, Presentation, Prevention and Treatment with Rifampicin
- Open Access
- 31 October 2019
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 16 (10) , e1002961
High-resolution mapping of tuberculosis transmission: Whole genome sequencing and phylogenetic modelling of a cohort from Valencia Region, Spain
Whole genome sequencing provides better delineation of transmission clusters in Mycobacterium tuberculosis than traditional methods. However, its ability to reveal individual transmission links within clusters is limited. Here, we used a 2-step approach based on Bayesian transmission reconstruction to (1) identify likely index and missing cases, (2) determine risk factors associated with transmitters, and (3) estimate when transmission happened. We developed our transmission reconstruction method using genomic and epidemiological data from a population-based study from Valencia Region, Spain. Tuberculosis (TB) incidence during the study period was 8.4 cases per 100,000 people. While the study is ongoing, the sampling frame for this work includes notified TB cases between 1 January 2014 and 31 December 2016. We identified a total of 21 transmission clusters that fulfilled the criteria for analysis. These contained a total of 117 individuals diagnosed with active TB (109 with epidemiological data). Demographic characteristics of the study population were as follows: 80/109 (73%) individuals were Spanish-born, 76/109 (70%) individuals were men, and the mean age was 42.51 years (SD 18.46). We found that 66/109 (61%) TB patients were sputum positive at diagnosis, and 10/109 (9%) were HIV positive. We used the data to reveal individual transmission links, and to identify index cases, missing cases, likely transmitters, and associated transmission risk factors. Our Bayesian inference approach suggests that at least 60% of index cases are likely misidentified by local public health. Our data also suggest that factors associated with likely transmitters are different to those of simply being in a transmission cluster, highlighting the importance of differentiating between these 2 phenomena. Our data suggest that type 2 diabetes mellitus is a risk factor associated with being a transmitter (odds ratio 0.19 [95% CI 0.02–1.10], p < 0.003). Finally, we used the most likely timing for transmission events to study when TB transmission occurred; we identified that 5/14 (35.7%) cases likely transmitted TB well before symptom onset, and these were largely sputum negative at diagnosis. Limited within-cluster diversity does not allow us to extrapolate our findings to the whole TB population in Valencia Region. In this study, we found that index cases are often misidentified, with downstream consequences for epidemiological investigations because likely transmitters can be missed. Our findings regarding inferred transmission timing suggest that TB transmission can occur before patient symptom onset, suggesting also that TB transmits during sub-clinical disease. This result has direct implications for diagnosing TB and reducing transmission. Overall, we show that a transition to individual-based genomic epidemiology will likely close some of the knowledge gaps in TB transmission and may redirect efforts towards cost-effective contact investigations for improved TB control.
- 31 October 2019
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 16 (10) , e1002961
Open AccessHigh-resolution mapping of tuberculosis transmission: Whole genome sequencing and phylogenetic modelling of a cohort from Valencia Region, Spain
Whole genome sequencing provides better delineation of transmission clusters in Mycobacterium tuberculosis than traditional methods. However, its ability to reveal individual transmission links within clusters is limited. Here, we used a 2-step approach based on Bayesian transmission reconstruction to (1) identify likely index and missing cases, (2) determine risk factors associated with transmitters, and (3) estimate when transmission happened. We developed our transmission reconstruction method using genomic and epidemiological data from a population-based study from Valencia Region, Spain. Tuberculosis (TB) incidence during the study period was 8.4 cases per 100,000 people. While the study is ongoing, the sampling frame for this work includes notified TB cases between 1 January 2014 and 31 December 2016. We identified a total of 21 transmission clusters that fulfilled the criteria for analysis. These contained a total of 117 individuals diagnosed with active TB (109 with epidemiological data). Demographic characteristics of the study population were as follows: 80/109 (73%) individuals were Spanish-born, 76/109 (70%) individuals were men, and the mean age was 42.51 years (SD 18.46). We found that 66/109 (61%) TB patients were sputum positive at diagnosis, and 10/109 (9%) were HIV positive. We used the data to reveal individual transmission links, and to identify index cases, missing cases, likely transmitters, and associated transmission risk factors. Our Bayesian inference approach suggests that at least 60% of index cases are likely misidentified by local public health. Our data also suggest that factors associated with likely transmitters are different to those of simply being in a transmission cluster, highlighting the importance of differentiating between these 2 phenomena. Our data suggest that type 2 diabetes mellitus is a risk factor associated with being a transmitter (odds ratio 0.19 [95% CI 0.02–1.10], p < 0.003). Finally, we used the most likely timing for transmission events to study when TB transmission occurred; we identified that 5/14 (35.7%) cases likely transmitted TB well before symptom onset, and these were largely sputum negative at diagnosis. Limited within-cluster diversity does not allow us to extrapolate our findings to the whole TB population in Valencia Region. In this study, we found that index cases are often misidentified, with downstream consequences for epidemiological investigations because likely transmitters can be missed. Our findings regarding inferred transmission timing suggest that TB transmission can occur before patient symptom onset, suggesting also that TB transmits during sub-clinical disease. This result has direct implications for diagnosing TB and reducing transmission. Overall, we show that a transition to individual-based genomic epidemiology will likely close some of the knowledge gaps in TB transmission and may redirect efforts towards cost-effective contact investigations for improved TB control.
- Open Access
- 25 October 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-12
Development and application of affordable SNP typing approaches to genotype Mycobacterium tuberculosis complex strains in low and high burden countries
The Mycobacterium tuberculosis complex (MTBC) comprises the species that causes tuberculosis (TB) which affects 10 million people every year. A robust classification of species, lineages, and sub-lineages is important to explore associations with drug resistance, epidemiological patterns or clinical outcomes. We present a rapid and easy-to-follow methodology to classify clinical TB samples into the main MTBC clades. Approaches are based on the identification of lineage and sub-lineage diagnostic SNP using a real-time PCR high resolution melting assay and classic Sanger sequencing from low-concentrated, low quality DNA. Thus, suitable for implementation in middle and low-income countries. Once we validated our molecular procedures, we characterized a total of 491 biological samples from human and cattle hosts, representing countries with different TB burden. Overall, we managed to genotype ~95% of all samples despite coming from unpurified and low-concentrated DNA. Our approach also allowed us to detect zoonotic cases in eight human samples from Nigeria. To conclude, the molecular techniques we have developed, are accurate, discriminative and reproducible. Furthermore, it costs less than other classic typing methods, resulting in an affordable alternative method in TB laboratories.
- 25 October 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-12
Open AccessDevelopment and application of affordable SNP typing approaches to genotype Mycobacterium tuberculosis complex strains in low and high burden countries
The Mycobacterium tuberculosis complex (MTBC) comprises the species that causes tuberculosis (TB) which affects 10 million people every year. A robust classification of species, lineages, and sub-lineages is important to explore associations with drug resistance, epidemiological patterns or clinical outcomes. We present a rapid and easy-to-follow methodology to classify clinical TB samples into the main MTBC clades. Approaches are based on the identification of lineage and sub-lineage diagnostic SNP using a real-time PCR high resolution melting assay and classic Sanger sequencing from low-concentrated, low quality DNA. Thus, suitable for implementation in middle and low-income countries. Once we validated our molecular procedures, we characterized a total of 491 biological samples from human and cattle hosts, representing countries with different TB burden. Overall, we managed to genotype ~95% of all samples despite coming from unpurified and low-concentrated DNA. Our approach also allowed us to detect zoonotic cases in eight human samples from Nigeria. To conclude, the molecular techniques we have developed, are accurate, discriminative and reproducible. Furthermore, it costs less than other classic typing methods, resulting in an affordable alternative method in TB laboratories.
- Open Access
- 3 October 2019
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 36 (4) , 985-989
Towards next-generation diagnostics for tuberculosis: identification of novel molecular targets by large-scale comparative genomics
Tuberculosis (TB) remains one of the main causes of death worldwide. The long and cumbersome process of culturing Mycobacterium tuberculosis complex (MTBC) bacteria has encouraged the development of specific molecular tools for detecting the pathogen. Most of these tools aim to become novel TB diagnostics, and big efforts and resources are invested in their development, looking for the endorsement of the main public health agencies. Surprisingly, no study has been conducted where the vast amount of genomic data available is used to identify the best MTBC diagnostic markers. In this work, we used large-scale comparative genomics to identify 40 MTBC-specific loci. We assessed their genetic diversity and physiological features to select 30 that are good targets for diagnostic purposes. Some of these markers could be used to assess the physiological status of the bacilli. Remarkably, none of the most used MTBC markers is in our catalog. Illustrating the translational potential of our work, we develop a specific qPCR assay for quantification and identification of MTBC DNA. Our rational design of targeted molecular assays for TB could be used in many other fields of clinical and basic research. The database of non-tuberculous mycobacteria assemblies can be accessed at: 10.5281/zenodo.3374377. Supplementary data are available at Bioinformatics online.
- 3 October 2019
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 36 (4) , 985-989
Open AccessTowards next-generation diagnostics for tuberculosis: identification of novel molecular targets by large-scale comparative genomics
Tuberculosis (TB) remains one of the main causes of death worldwide. The long and cumbersome process of culturing Mycobacterium tuberculosis complex (MTBC) bacteria has encouraged the development of specific molecular tools for detecting the pathogen. Most of these tools aim to become novel TB diagnostics, and big efforts and resources are invested in their development, looking for the endorsement of the main public health agencies. Surprisingly, no study has been conducted where the vast amount of genomic data available is used to identify the best MTBC diagnostic markers. In this work, we used large-scale comparative genomics to identify 40 MTBC-specific loci. We assessed their genetic diversity and physiological features to select 30 that are good targets for diagnostic purposes. Some of these markers could be used to assess the physiological status of the bacilli. Remarkably, none of the most used MTBC markers is in our catalog. Illustrating the translational potential of our work, we develop a specific qPCR assay for quantification and identification of MTBC DNA. Our rational design of targeted molecular assays for TB could be used in many other fields of clinical and basic research. The database of non-tuberculous mycobacteria assemblies can be accessed at: 10.5281/zenodo.3374377. Supplementary data are available at Bioinformatics online.
- 1 January 2019
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 37 (1) , 58-59
Placa granulomatosa en la rodilla derecha de un niño de 10 años de edad
- 1 January 2019
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 37 (1) , 58-59
Placa granulomatosa en la rodilla derecha de un niño de 10 años de edad
- 1 January 2019
- Published by Elsevier in Enfermedades Infecciosas y Microbiologia Clinica (English Ed.)
- Vol. 37 (1) , 58-59
Granulomatous plaque of the right knee in a 10-year-old boy
- 1 January 2019
- Published by Elsevier in Enfermedades Infecciosas y Microbiologia Clinica (English Ed.)
- Vol. 37 (1) , 58-59
Granulomatous plaque of the right knee in a 10-year-old boy